Breast Cancer, Version 3.2013

Restricted access

These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.

Supplementary Materials

    • Supplemental Material (PDF 178 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 604 440 16
PDF Downloads 107 62 4
EPUB Downloads 0 0 0